A catalyst for technology-based economic development in life sciences . In 1984, three of North Carolina’s largest ...

Novartis has operated in North Carolina for more than two decades, delivering gene therapies and other lifesaving treatments ...

Mucommune, a Morrisville-based biotechnology company with roots at the University of North Carolina at Chapel Hill, has been ...

New legislation proposed by a bipartisan and bicameral group of Congressional legislators and supported by the North Carolina ...

Precise Bio Inc., a Greensboro-based clinical-stage regenerative medicine company, has announced the world’s first transplant ...

Join AgBio+AgTech at the First Flight Venture Center for a conversation with Dr. Sharon Inch, plant pathologist and innovator behind Soil Sync and AgVision Analytics. Dr. Inch will share how she ...

Join Innovate Carolina on December 4 for an evening celebrating innovation, invention, and the journey from academic discovery to real-world impact.

Innatrix‘s lead product, InnaNema, targets soybean cyst nematode, one of the most damaging pests for U.S. soybean crops.

If you want to know how therapeutic innovation in the Triangle stacks up against other life sciences hubs, just ask an investor who knows the national and global landscape. Nima Ronaghi, principal at ...

Wilmington-based Predicate AI Labs Inc. has entered a collaboration with the Mayo Clinic to advance the early detection of sepsis, the leading cause of mortality worldwide. The healthcare technology ...

Novartis Gene Therapies, a division of Switzerland-based Novartis, one of the world’s largest pharmaceutical companies, plans to expand in the Research Triangle with $771 million of investments at ...